相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Catalysis and Mechanistic Insights into Sirtuin Activation
Kristin E. Dittenhafer-Reed et al.
CHEMBIOCHEM (2011)
C/EBP alpha and PU.1 are involved in distinct differentiation responses of acute promyelocytic leukemia HL-60 and NB4 cells via chromatin remodeling
Jurate Savickiene et al.
DIFFERENTIATION (2011)
Phenylbutyrate therapy for maple syrup urine disease
Nicola Brunetti-Pierri et al.
HUMAN MOLECULAR GENETICS (2011)
Allyl-, butyl- and phenylethyl-isothiocyanate activate Nrf2 in cultured fibroblasts
Insa M. A. Ernst et al.
PHARMACOLOGICAL RESEARCH (2011)
Molecular Targets of Dietary Phenethyl Isothiocyanate and Sulforaphane for Cancer Chemoprevention
Ka Lung Cheung et al.
AAPS JOURNAL (2010)
Peptide Arrays Identify Isoform-Selective Substrates for Profiling Endogenous Lysine Deacetylase Activity
Zachary A. Gurard-Levin et al.
ACS CHEMICAL BIOLOGY (2010)
Deficient Histone Acetylation in Acute Leukemia and the Correction by an Isothiocyanate
Liyun Xiao et al.
ACTA HAEMATOLOGICA (2010)
Aging and disease: connections to sirtuins
Gizem Donmez et al.
AGING CELL (2010)
Identification of phenylbutyrate-generated metabolites in Huntington disease patients using parallel liquid chromatography/electrochemical array/mass spectrometry and off-line tandem mass spectrometry
Erika N. Ebbel et al.
ANALYTICAL BIOCHEMISTRY (2010)
Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals
Bharat B. Aggarwal
ANNUAL REVIEW OF NUTRITION, VOL 30 (2010)
Polyphenols and health: Update and perspectives
Helmut Sies
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Regulation of SIRT1 in cellular functions: Role of polyphenols
Sangwoon Chung et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Bioavailability of chlorogenic acids following acute ingestion of coffee by humans with an ileostomy
Angelique Stalmach et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Clearance of Mutant Proteins as a Therapeutic Target in Neurodegenerative Diseases
Dimitri Krainc
ARCHIVES OF NEUROLOGY (2010)
Pleiotropic mechanisms facilitated by resveratrol and its metabolites
Barbara Calamini et al.
BIOCHEMICAL JOURNAL (2010)
SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors
Dhimant Desai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Metabolism of green tea catechins by the human small intestine
Markus Schantz et al.
BIOTECHNOLOGY JOURNAL (2010)
Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound β-phenylethyl isothiocyanate
Yumin Hu et al.
BLOOD (2010)
Is Lamarckian evolution relevant to medicine?
Adam E. Handel et al.
BMC MEDICAL GENETICS (2010)
Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies
Jenny Epstein et al.
BRITISH JOURNAL OF NUTRITION (2010)
Identification of type-specific anticancer histone deacetylase inhibitors: road to success
Nighat Noureen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy
Peter M. Wilson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Chemopreventive Agent 3,3′-Diindolylmethane Selectively Induces Proteasomal Degradation of Class I Histone Deacetylases
Yongming Li et al.
CANCER RESEARCH (2010)
ATP Consumption Promotes Cancer Metabolism
William J. Israelsen et al.
CELL (2010)
The Language of Histone Crosstalk
Jung-Shin Lee et al.
CELL (2010)
Protein Acetylation in the Cardiorenal Axis The Promise of Histone Deacetylase Inhibitors
Erik W. Bush et al.
CIRCULATION RESEARCH (2010)
Fooling Mother Nature: Epigenetics and Novel Treatments for Psychiatric Disorders
Stephen M. Stahl
CNS SPECTRUMS (2010)
Modifying chromatin architecture during the response to DNA breakage
Ashok R. Venkitaraman
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Keeping it in the family: diverse histone recognition by conserved structural folds
Kyoko L. Yap et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Decoding the histone H4 lysine 20 methylation mark
Lata Balakrishnan et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Anticancer Properties of Indole Compounds: Mechanism of Apoptosis Induction and Role in Chemotherapy
Aamir Ahmad et al.
CURRENT DRUG TARGETS (2010)
Reversing Aberrant Methylation Patterns in Cancer
F. S. Poke et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Flavonoids Influence Epigenetic-Modifying Enzyme Activity: Structure-Function Relationships and the Therapeutic Potential for Cancer
E. R. Gilbert et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Manipulation of Glycolysis in Malignant Tumors: Fantasy or Therapy?
U. G. A. Sattler et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Sirtuin Family: A Link to Metabolic Signaling and Senescence
S. Kyrylenko et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
G. Bar-Sela et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Impact on DNA Methylation in Cancer Prevention and Therapy by Bioactive Dietary Components
Y. Li et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Lysine deacetylases are produced in pancreatic beta cells and are differentially regulated by proinflammatory cytokines
M. Lundh et al.
DIABETOLOGIA (2010)
Role of Sirtuin 1 in metabolic regulation
Jose P. Silva et al.
DRUG DISCOVERY TODAY (2010)
Overcoming Reduced Glucocorticoid Sensitivity in Airway Disease Molecular Mechanisms and Therapeutic Approaches
John A. Marwick et al.
DRUGS (2010)
HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy
Joo-Yong Lee et al.
EMBO JOURNAL (2010)
Targeting Mitochondria for Cancer Therapy
David M. Hockenbery
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2010)
Nonhistone protein acetylation as cancer therapy targets
Brahma N. Singh et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Selenium or No Selenium-That Is the Question in Tumor Patients: A New Controversy
Ralph Muecke et al.
INTEGRATIVE CANCER THERAPIES (2010)
Blockade of Dendritic Cell Development by Bacterial Fermentation Products Butyrate and Propionate through a Transporter (Slc5a8)-dependent Inhibition of Histone Deacetylases
Nagendra Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Phase I Study of Vorinostat in Patients With Advanced Solid Tumors and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study
Suresh S. Ramalingam et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
Sean J. Whittaker et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Pediatric Phase I Trial and Pharmacokinetic Study of Vorinostat: A Children's Oncology Group Phase I Consortium Report
Maryam Fouladi et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Reactivating aberrantly hypermethylated p15 gene in leukemic T cells by a phenylhexyl isothiocyanate mediated inter-active mechanism on DNA and chromatin
Shaohong Jiang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
Conformational Refinement of Hydroxamate-Based Histone Deacetylase Inhibitors and Exploration of 3-Piperidin-3-ylindole Analogues of Dacinostat (LAQ824)
Young Shin Cho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Novel 3-Arylideneindolin-2-ones as Inhibitors of NAD+-Dependent Histone Deacetylases (Sirtuins)
Kilian Huber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Biological and Biophysical Properties of the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Are Affected by the Presence of Short Alkyl Groups on the Phenyl Ring
Frederik Oger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
A Cereal-Based Evening Meal Rich in Indigestible Carbohydrates Increases Plasma Butyrate the Next Morning
Anne C. Nilsson et al.
JOURNAL OF NUTRITION (2010)
Mechanisms and resistance in glucocorticoid control of inflammation
Peter J. Barnes
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Perspectives on Chemopreventive and Therapeutic Potential of Curcumin Analogs in Medicinal Chemistry
S. Padhye et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2010)
Benzyl Isothiocyanate-Mediated Inhibition of Histone Deacetylase Leads to NF-KB Turnoff in Human Pancreatic Carcinoma Cells
Sanjay Batra et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Absorption, metabolism, and excretion of green tea flavan-3-ols in humans with an ileostomy
Angelique Stalmach et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2010)
New Therapies for Chronic Obstructive Pulmonary Disease
Peter J. Barnes
MEDICAL PRINCIPLES AND PRACTICE (2010)
Deoxycholic Acid and Selenium Metabolite Methylselenol Exert Common and Distinct Effects on Cell Cycle, Apoptosis, and MAP Kinase Pathway in HCT116 Human Colon Cancer Cells
Huawei Zeng et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2010)
Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines
Syed M. Meeran et al.
PLOS ONE (2010)
Regulation of microRNAs by Natural Agents: An Emerging Field in Chemoprevention and Chemotherapy Research
Yiwei Li et al.
PHARMACEUTICAL RESEARCH (2010)
A pharmacogenetic study of vorinostat glucuronidation
Soonmo Peter Kang et al.
PHARMACOGENETICS AND GENOMICS (2010)
Histone deacetylases and epigenetic therapies of hematological malignancies
Ciro Mercurio et al.
PHARMACOLOGICAL RESEARCH (2010)
A possibility of nutriceuticals as an anti-aging intervention: Activation of sirtuins by promoting mammalian NAD biosynthesis
Shin-ichiro Imai
PHARMACOLOGICAL RESEARCH (2010)
Histone deacetylase inhibitors: Keeping momentum for neuromuscular and cardiovascular diseases treatment
Claudia Colussi et al.
PHARMACOLOGICAL RESEARCH (2010)
Pharmacological manipulations of CNS sirtuins: Potential effects on metabolic homeostasis
Giorgio Ramadori et al.
PHARMACOLOGICAL RESEARCH (2010)
Protein deacetylation by SIRT1: An emerging key post-translational modification in metabolic regulation
Jiujiu Yu et al.
PHARMACOLOGICAL RESEARCH (2010)
HDAC inhibitors and neurodegeneration: At the edge between protection and damage
Karen C. Dietz et al.
PHARMACOLOGICAL RESEARCH (2010)
Cancer Prevention With Natural Compounds
Norleena P. Collett et al.
SEMINARS IN ONCOLOGY (2010)
Targeting NRF2 signaling for cancer chemoprevention
Mi-Kyoung Kwak et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases
Shin-ichiro Imai et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer
Amy Sharma et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2010)
Covalent histone modifications - miswritten, misinterpreted and mis-erased in human cancers
Ping Chi et al.
NATURE REVIEWS CANCER (2010)
Histone Deacetylase 2 Is Phosphorylated, Ubiquitinated, and Degraded by Cigarette Smoke
David Adenuga et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Phase 2 study of sodium phenylbutyrate in ALS
Merit E. Cudkowicz et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Role of HDAC2 in the Pathophysiology of COPD
Peter J. Barnes
ANNUAL REVIEW OF PHYSIOLOGY (2009)
Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3
Muthusamy Thangaraju et al.
BIOCHEMICAL JOURNAL (2009)
Mustard Oil in Shibori Daikon a Variety of Japanese Radish, Selectively Inhibits the Proliferation of H-ras-Transformed 3Y1 Cells
Masao Yamasaki et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2009)
A study protocol to investigate the relationship between dietary fibre intake and fermentation, colon cell turnover, global protein acetylation and early carcinogenesis: the FACT study
Bernard M. Corfe et al.
BMC CANCER (2009)
DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines
Melissa J. LaBonte et al.
BMC MEDICAL GENOMICS (2009)
Transport by SLC5A8 With Subsequent Inhibition of Histone Deacetylase 1 (HDAC1) and HDAC3 Underlies the Antitumor Activity of 3-bromopyruvate
Muthusamy Thangaraju et al.
CANCER (2009)
α-Keto Acid Metabolites of Naturally Occurring Organoselenium Compounds as Inhibitors of Histone Deacetylase in Human Prostate Cancer Cells
Jeong-In Lee et al.
CANCER PREVENTION RESEARCH (2009)
α-Keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells
Hui Nian et al.
CARCINOGENESIS (2009)
Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
Ina Oehme et al.
CLINICAL CANCER RESEARCH (2009)
Butyrate modulates oxidative stress in the colonic mucosa of healthy humans
Henrike M. Hamer et al.
CLINICAL NUTRITION (2009)
Current Perspectives on Role of Chromatin Modifications and Deacetylases in Lung Inflammation in COPD
Saravanan Rajendrasozhan et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2009)
SIRT1 and caloric restriction: an insight into possible trade-offs between robustness and frailty
Shin-ichiro Imai
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2009)
Curcumin has Bright Prospects for the Treatment of Inflammatory Bowel Disease
Hiroyuki Hanai et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Computational Studies on the Histone Deacetylases and the Design of Selective Histone Deacetylase Inhibitors
Difei Wang
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Novel Structural Insights into Class I and II Histone Deacetylases
Ralf Ficner
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Global Histone H4 Acetylation and HDAC2 Expression in Colon Adenoma and Carcinoma
Hassan Ashktorab et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Antioxidant and Pro-Oxidant Capacities of ITCs
Luca Valgimigli et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2009)
Biological Properties of Garlic and Garlic-Derived Organosulfur Compounds
Malgorzata Iciek et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2009)
Modulation of Histone Deacetylase Activity by Dietary Isothiocyanates and Allyl Sulfides: Studies with Sulforaphane and Garlic Organosulfur Compounds
Hui Nian et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2009)
Targeting of HDAC8 and investigational inhibitors in neuroblastoma
Ina Oehme et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: Efficacy of tributyrin, a butyric acid prodrug
Joice Kuroiwa-Trzmielina et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells
Su Dan Xiong et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers The Selenium and Vitamin E Cancer Prevention Trial ( SELECT)
Scott M. Lippman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
被撤回的出版物: HDAC6 Modulates Hsp90 Chaperone Activity and Regulates Activation of Aryl Hydrocarbon Receptor Signaling (Retracted article. See vol. 295, pg. 297, 2020)
Vikram D. Kekatpure et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Histone Deacetylase Inhibitors: Potential in Cancer Therapy
P. A. Marks et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Docking of Hydroxamic Acids into HDAC1 and HDAC8: A Rationalization of Activity Trends and Selectivities
Gabriella Ortore et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Potential Role of Sirtuin as a Therapeutic Target for Neurodegenerative Diseases
Seol-Heui Han
JOURNAL OF CLINICAL NEUROLOGY (2009)
Histone Deacetylase Inhibitors in Cancer Therapy
Andrew A. Lane et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
MicroRNAs in Cancer: Small Molecules With a Huge Impact
Marilena V. Iorio et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
Evanthia Galanis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Design, Synthesis, and Biological Activity of Boronic Acid-Based Histone Deacetylase Inhibitors
Nobuaki Suzuki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Selenium metabolism in rats with long-term ingestion of Se-methylselenocysteine using enriched stable isotopes
Yoshiro Tsuji et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2009)
Glucosinolates in Brassica vegetables: The influence of the food supply chain on intake, bioavailability and human health
Ruud Verkerk et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond
Vadivel Ganapathy et al.
PHARMACOLOGY & THERAPEUTICS (2009)
HDAC6 is a target for protection and regeneration following injury in the nervous system
Mark A. Rivieccio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Histone Deacetylase Inhibitors Target Diabetes via Chromatin Remodeling or as Chemical Chaperones?
M. W. Lawless et al.
CURRENT DIABETES REVIEWS (2009)
Sodium-coupled monocarboxylate transporters in normal tissues and in cancer
Vadivel Ganapathy et al.
AAPS JOURNAL (2008)
Surrogate alcohols and their metabolites modify histone H3 acetylation: Involvement of histone acetyl transferase and histone deacetylase
Mahua Choudhury et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2
Koremu K. Meja et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Dietary manipulation of histone structure and function
Barbara Delage et al.
ANNUAL REVIEW OF NUTRITION (2008)
Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors
Jung-Hyun Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Structural Studies of Human Histone Deacetylase 8 and Its Site-Specific Variants Complexed with Substrate and Inhibitors
Daniel P. Dowling et al.
BIOCHEMISTRY (2008)
Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
Florian R. Fritzsche et al.
BMC CANCER (2008)
Multi-targeted prevention of cancer by sulforaphane
John D. Clarke et al.
CANCER LETTERS (2008)
Indole-3-carbinol as a chemopreventive and anti-cancer agent
Jing-Ru Weng et al.
CANCER LETTERS (2008)
Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds
Anna A. Powolny et al.
CANCER LETTERS (2008)
Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter
Hui Nian et al.
CARCINOGENESIS (2008)
HDAC6 a new cellular stress surveillance factor
Patrick Matthias et al.
CELL CYCLE (2008)
Selenium and anticarcinogenesis: underlying mechanisms
Matthew I. Jackson et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2008)
From natural products to small molecule ketone histone deacetylase inhibitors:: Development of new class specific agents
Philip Jones et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
HDACs and HDAC inhibitors in colon cancer
John M. Mariadason
EPIGENETICS (2008)
The role of histone deacetylases in prostate cancer
Ata Abbas et al.
EPIGENETICS (2008)
Pimelic Diphenylamide 106 Is a Slow, Tight-binding Inhibitor of Class I Histone Deacetylases
C. James Chou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain
Matthew J. Bottomley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity
Anja Schuetz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Histone deacetylase 6 interacts with the microtubule-associated protein tau
Huiping Ding et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon
Markus Waldecker et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2008)
Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model
Akihiko Miyanaga et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Curcumin in cancer management: Recent results of analogue design and clinical studies and desirable future research
William P. Steward et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
Metabolism of curcumin and induction of mitotic catastrophe in human cancer cells
Julia S. Dempe et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
Xiang-Jiao Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Cellular Stress Response: A Novel Target for Chemoprevention and Nutritional Neuroprotection in Aging, Neurodegenerative Disorders and Longevity
Vittorio Calabrese et al.
NEUROCHEMICAL RESEARCH (2008)
Histone-deacetylase inhibition and butyrate formation: Fecal slurry incubations with apple pectin and apple juice extracts
Markus Waldecker et al.
NUTRITION (2008)
Diallyl disulfide increases histone acetylation in colon cells in vitro and in vivo
Nathalie Druesne-Pecollo et al.
NUTRITION REVIEWS (2008)
Dietary Components Impact Histone Modifications and Cancer Risk
Cindy D. Davis et al.
NUTRITION REVIEWS (2008)
Evidence for dietary regulation of microRNA expression in cancer cells
Cindy D. Davis et al.
NUTRITION REVIEWS (2008)
Dietary polyphenols mediated regulation of oxidative stress and chromatin remodeling in inflammation
Irfan Rahman
NUTRITION REVIEWS (2008)
Methylation and demethylation of intermediates selenide and methylselenol in the metabolism of selenium
Yuki Ohta et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate
Anoushe Sekhavat et al.
BIOCHEMISTRY AND CELL BIOLOGY (2007)
Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells
T. Sanda et al.
LEUKEMIA (2007)
Sodium phenylbutyrate in Huntington's disease: A dose-finding study
Penelope Hogarth et al.
MOVEMENT DISORDERS (2007)
Dietary histone deacetylase inhibitors: From cells to mice to man
Roderick H. Dashwood et al.
SEMINARS IN CANCER BIOLOGY (2007)
Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex
Alessandro Vannini et al.
EMBO REPORTS (2007)
Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases
Simone I. Hoehle et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2007)
HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS
Udai Bhan Pandey et al.
NATURE (2007)
Soyoligosaccharide increases fecal bifidobacteria counts, short-chain fatty acids, and fecal lipid concentrations in young Korean women
Myung Hee Bang et al.
JOURNAL OF MEDICINAL FOOD (2007)
Histone deacetylase inhibitors: Molecular and biological activity as a premise to clinical application
V. Santini et al.
CURRENT DRUG METABOLISM (2007)
Molecular basis for chemoprevention by sulforaphane: a comprehensive review
N. Juge et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
In vivo treatment by diallyl disulfide increases histone acetylation in rat colonocytes
Nathalie Druesne-Pecollo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines
Allison Pledgie-Tracy et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Dimethyl sulfoxide to vorinostat: Development of this histone deacetylase inhibitor as an anticancer drug
Paul A. Marks et al.
NATURE BIOTECHNOLOGY (2007)
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma, (CTCL)
Madeleine Duvic et al.
BLOOD (2007)
Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis
Jane V. Higdon et al.
PHARMACOLOGICAL RESEARCH (2007)
Dietary agents as histone deacetylase inhibitors
Melinda C. Myzak et al.
MOLECULAR CARCINOGENESIS (2006)
Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis
S Petri et al.
NEUROBIOLOGY OF DISEASE (2006)
Histone deacetylases as targets for dietary cancer preventive agents: Lessons learned with butyrate, diallyl disulfide, and sulforaphane
MC Myzak et al.
CURRENT DRUG TARGETS (2006)
Chemoprotection by sulforaphane: Keep one eye beyond Keap1
MC Myzak et al.
CANCER LETTERS (2006)
Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention?
RH Dashwood et al.
CARCINOGENESIS (2006)
Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies
OA O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Selenium and cancer chemoprevention:: Hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells
JX Lü et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids
WJ Lee et al.
MOLECULAR PHARMACOLOGY (2005)
Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90 - A novel basis for antileukemia activity of histone deacetylase inhibitors
P Bali et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer
WK Kelly et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice
H Ryu et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Differential roles for the coactivators CBP and p300 on TCF/β-catenin-mediated survivin gene expression
H Ma et al.
ONCOGENE (2005)
Novel inhibitors of human histone deacetylases: Design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SARA-based non-hydroxamates
T Suzuki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease
G Gardian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Molecular targets and anticancer potential of indole-3-carbinol and its derivatives
BB Aggarwal et al.
CELL CYCLE (2005)
A novel mechanism of chemoprotection by sulforaphane: Inhibition of histone deacetylase
MC Myzak et al.
CANCER RESEARCH (2004)
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
JG Wood et al.
NATURE (2004)
Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases
JR Somoza et al.
STRUCTURE (2004)
Diallyl disulfide (DADS) increases histone acetylation and p21waf1/cip1 expression in human colon tumor cell lines
N Druesne et al.
CARCINOGENESIS (2004)
Thiol-based SAHA analogues as potent histone deacetylase inhibitors
T Suzuki et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor
A Vannini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance
RA Sharma et al.
CLINICAL CANCER RESEARCH (2004)
Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin A after intraperitoneal administration to mice
L Sanderson et al.
DRUG METABOLISM AND DISPOSITION (2004)
Histone, deacetylase inhibitor trichostatin a induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells
Y Yamashita et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
From discovery to the coming generation of histone deacetylase inhibitors
M Yoshida et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Major phase I biotransformation pathways of trichostatin A in rat hepatocytes and in rat and human liver microsomes
G Elaut et al.
DRUG METABOLISM AND DISPOSITION (2002)
HDAC6 is a microtubule-associated deacetylase
C Hubbert et al.
NATURE (2002)
Induction of histone acetylation and inhibition of growth of mouse erythroleukemia cells by S-allylmercaptocysteine
MA Lea et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2002)
Histone deacetylase and DNA methyltransferase in human prostate cancer
SK Patra et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Induction of histone acetylation in mouse erythroleukemia cells by some organosulfur compounds including allyl isothiocyanate
MA Lea et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
分享论文
